Effects of clomipramine administration on Syrian hamster circadian system and behavior

Paola C. Yannielli, Martín Cadeiras, Liz Gregoretti, Lucila Kargieman, Daniel P. Cardinali, Diego A. Golombek

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The aim of the present work is to discuss the available data on neonatal and adult antidepressant treatment in relation to animal models of depression and serotonergic modulation of the circadian system, with a particular emphasis on our own published and unpublished work on the effects of clomipramine (a serotonin reuptake inhibitor) on the Syrian hamster circadian behavior. Neonatal clomipramine treatment (15 mg/kg from postnatal days 8 to 21) significantly augmented the amplitude of the wheel running rhythm, as well as delayed its acrophase and increased the time to reentrain after a 6-h phase advance of the light-dark cycle. Neonatally clomipramine-treated hamsters had a shorter circadian period than saline-treated animals under constant light - but not under constant dark- conditions, exhibited decreased phase advances after light pulses applied at late subjective night and greater phase advances after i.p. administration of the 5-HT1(A)-receptor agonist 8-OH-DPA at midday. These animals also exhibited more locomotor activity than controls, but did not display the typical circadian variation in anxiety-related behavior, as measured in a plus-maze paradigm. They also showed an increased 5-HIAA/5-HT ratio in hypothalamus and midbrain raphe, while 5-HT content was decreased in frontal cortex and anterior hypothalamic areas. Since drugs linked to the serotonergic system are able to modify the circadian system, we decided to test whether acute and chronic clomipramine administration in adulthood was able to change: a) the phase of free running activity rhythms; (b) light-induced phase shifts, and (c) hypothalamic 5-HT turnover. Acute clomipramine injection had a phase-dependent effect on the free running activity rhythm, with phase advances at CT 0-8 being significantly higher than at CT 8-16. Pretreatment with clomipramine inhibited phase advances in response to light pulses when applied at CT 19 while phase delays at CT 14 remained unaffected. This acute treatment also decreased 5-HT turnover in the SCN at both CTs. In contrast, chronic clomipramine administration potentiated light-induced phase advances, without changes in period, amplitude or central 5-HT turnover. Taken together, these data support the view that clomipramine, as other antidepressant drugs, can affect the expression of the circadian rhythmicity in Syrian hamsters, possibly through serotonergic mechanisms in the case of acute treatments, and more complex behavioral interaction in the case of neonatal and chronic treatments.

Original languageEnglish (US)
Pages (from-to)391-415
Number of pages25
JournalBiological Rhythm Research
Volume31
Issue number3
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Clomipramine
Mesocricetus
serotonin
Serotonin
antidepressants
turnover
Light
Running
animal
drug
Antidepressive Agents
Serotonin 5-HT1 Receptors
Anterior Hypothalamic Nucleus
anxiety
phase transition
wheels
hypothalamus
adulthood
hamsters
agonists

ASJC Scopus subject areas

  • Physiology
  • Ecology, Evolution, Behavior and Systematics
  • Physiology (medical)

Cite this

Effects of clomipramine administration on Syrian hamster circadian system and behavior. / Yannielli, Paola C.; Cadeiras, Martín; Gregoretti, Liz; Kargieman, Lucila; Cardinali, Daniel P.; Golombek, Diego A.

In: Biological Rhythm Research, Vol. 31, No. 3, 01.01.2000, p. 391-415.

Research output: Contribution to journalReview article

Yannielli, Paola C. ; Cadeiras, Martín ; Gregoretti, Liz ; Kargieman, Lucila ; Cardinali, Daniel P. ; Golombek, Diego A. / Effects of clomipramine administration on Syrian hamster circadian system and behavior. In: Biological Rhythm Research. 2000 ; Vol. 31, No. 3. pp. 391-415.
@article{5443caeb593d480793b75f147d17cef8,
title = "Effects of clomipramine administration on Syrian hamster circadian system and behavior",
abstract = "The aim of the present work is to discuss the available data on neonatal and adult antidepressant treatment in relation to animal models of depression and serotonergic modulation of the circadian system, with a particular emphasis on our own published and unpublished work on the effects of clomipramine (a serotonin reuptake inhibitor) on the Syrian hamster circadian behavior. Neonatal clomipramine treatment (15 mg/kg from postnatal days 8 to 21) significantly augmented the amplitude of the wheel running rhythm, as well as delayed its acrophase and increased the time to reentrain after a 6-h phase advance of the light-dark cycle. Neonatally clomipramine-treated hamsters had a shorter circadian period than saline-treated animals under constant light - but not under constant dark- conditions, exhibited decreased phase advances after light pulses applied at late subjective night and greater phase advances after i.p. administration of the 5-HT1(A)-receptor agonist 8-OH-DPA at midday. These animals also exhibited more locomotor activity than controls, but did not display the typical circadian variation in anxiety-related behavior, as measured in a plus-maze paradigm. They also showed an increased 5-HIAA/5-HT ratio in hypothalamus and midbrain raphe, while 5-HT content was decreased in frontal cortex and anterior hypothalamic areas. Since drugs linked to the serotonergic system are able to modify the circadian system, we decided to test whether acute and chronic clomipramine administration in adulthood was able to change: a) the phase of free running activity rhythms; (b) light-induced phase shifts, and (c) hypothalamic 5-HT turnover. Acute clomipramine injection had a phase-dependent effect on the free running activity rhythm, with phase advances at CT 0-8 being significantly higher than at CT 8-16. Pretreatment with clomipramine inhibited phase advances in response to light pulses when applied at CT 19 while phase delays at CT 14 remained unaffected. This acute treatment also decreased 5-HT turnover in the SCN at both CTs. In contrast, chronic clomipramine administration potentiated light-induced phase advances, without changes in period, amplitude or central 5-HT turnover. Taken together, these data support the view that clomipramine, as other antidepressant drugs, can affect the expression of the circadian rhythmicity in Syrian hamsters, possibly through serotonergic mechanisms in the case of acute treatments, and more complex behavioral interaction in the case of neonatal and chronic treatments.",
author = "Yannielli, {Paola C.} and Mart{\'i}n Cadeiras and Liz Gregoretti and Lucila Kargieman and Cardinali, {Daniel P.} and Golombek, {Diego A.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1076/0929-1016(200007)31:3;1-K;FT391",
language = "English (US)",
volume = "31",
pages = "391--415",
journal = "Biological Rhythm Research",
issn = "0929-1016",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Effects of clomipramine administration on Syrian hamster circadian system and behavior

AU - Yannielli, Paola C.

AU - Cadeiras, Martín

AU - Gregoretti, Liz

AU - Kargieman, Lucila

AU - Cardinali, Daniel P.

AU - Golombek, Diego A.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - The aim of the present work is to discuss the available data on neonatal and adult antidepressant treatment in relation to animal models of depression and serotonergic modulation of the circadian system, with a particular emphasis on our own published and unpublished work on the effects of clomipramine (a serotonin reuptake inhibitor) on the Syrian hamster circadian behavior. Neonatal clomipramine treatment (15 mg/kg from postnatal days 8 to 21) significantly augmented the amplitude of the wheel running rhythm, as well as delayed its acrophase and increased the time to reentrain after a 6-h phase advance of the light-dark cycle. Neonatally clomipramine-treated hamsters had a shorter circadian period than saline-treated animals under constant light - but not under constant dark- conditions, exhibited decreased phase advances after light pulses applied at late subjective night and greater phase advances after i.p. administration of the 5-HT1(A)-receptor agonist 8-OH-DPA at midday. These animals also exhibited more locomotor activity than controls, but did not display the typical circadian variation in anxiety-related behavior, as measured in a plus-maze paradigm. They also showed an increased 5-HIAA/5-HT ratio in hypothalamus and midbrain raphe, while 5-HT content was decreased in frontal cortex and anterior hypothalamic areas. Since drugs linked to the serotonergic system are able to modify the circadian system, we decided to test whether acute and chronic clomipramine administration in adulthood was able to change: a) the phase of free running activity rhythms; (b) light-induced phase shifts, and (c) hypothalamic 5-HT turnover. Acute clomipramine injection had a phase-dependent effect on the free running activity rhythm, with phase advances at CT 0-8 being significantly higher than at CT 8-16. Pretreatment with clomipramine inhibited phase advances in response to light pulses when applied at CT 19 while phase delays at CT 14 remained unaffected. This acute treatment also decreased 5-HT turnover in the SCN at both CTs. In contrast, chronic clomipramine administration potentiated light-induced phase advances, without changes in period, amplitude or central 5-HT turnover. Taken together, these data support the view that clomipramine, as other antidepressant drugs, can affect the expression of the circadian rhythmicity in Syrian hamsters, possibly through serotonergic mechanisms in the case of acute treatments, and more complex behavioral interaction in the case of neonatal and chronic treatments.

AB - The aim of the present work is to discuss the available data on neonatal and adult antidepressant treatment in relation to animal models of depression and serotonergic modulation of the circadian system, with a particular emphasis on our own published and unpublished work on the effects of clomipramine (a serotonin reuptake inhibitor) on the Syrian hamster circadian behavior. Neonatal clomipramine treatment (15 mg/kg from postnatal days 8 to 21) significantly augmented the amplitude of the wheel running rhythm, as well as delayed its acrophase and increased the time to reentrain after a 6-h phase advance of the light-dark cycle. Neonatally clomipramine-treated hamsters had a shorter circadian period than saline-treated animals under constant light - but not under constant dark- conditions, exhibited decreased phase advances after light pulses applied at late subjective night and greater phase advances after i.p. administration of the 5-HT1(A)-receptor agonist 8-OH-DPA at midday. These animals also exhibited more locomotor activity than controls, but did not display the typical circadian variation in anxiety-related behavior, as measured in a plus-maze paradigm. They also showed an increased 5-HIAA/5-HT ratio in hypothalamus and midbrain raphe, while 5-HT content was decreased in frontal cortex and anterior hypothalamic areas. Since drugs linked to the serotonergic system are able to modify the circadian system, we decided to test whether acute and chronic clomipramine administration in adulthood was able to change: a) the phase of free running activity rhythms; (b) light-induced phase shifts, and (c) hypothalamic 5-HT turnover. Acute clomipramine injection had a phase-dependent effect on the free running activity rhythm, with phase advances at CT 0-8 being significantly higher than at CT 8-16. Pretreatment with clomipramine inhibited phase advances in response to light pulses when applied at CT 19 while phase delays at CT 14 remained unaffected. This acute treatment also decreased 5-HT turnover in the SCN at both CTs. In contrast, chronic clomipramine administration potentiated light-induced phase advances, without changes in period, amplitude or central 5-HT turnover. Taken together, these data support the view that clomipramine, as other antidepressant drugs, can affect the expression of the circadian rhythmicity in Syrian hamsters, possibly through serotonergic mechanisms in the case of acute treatments, and more complex behavioral interaction in the case of neonatal and chronic treatments.

UR - http://www.scopus.com/inward/record.url?scp=0033860516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033860516&partnerID=8YFLogxK

U2 - 10.1076/0929-1016(200007)31:3;1-K;FT391

DO - 10.1076/0929-1016(200007)31:3;1-K;FT391

M3 - Review article

AN - SCOPUS:0033860516

VL - 31

SP - 391

EP - 415

JO - Biological Rhythm Research

JF - Biological Rhythm Research

SN - 0929-1016

IS - 3

ER -